首页|体外细胞和类器官模型在炎症性肠病研究中的应用

体外细胞和类器官模型在炎症性肠病研究中的应用

扫码查看
选择与研究目的契合的体外实验模型对于炎症性肠病病理研究、治疗药物开发以及药理机制探索具有重要意义.永生化细胞系作为经典的体外模型,虽然在炎症性肠病研究及药物评价中具有高效、低成本、操作简便及实验结果直观等优势,但此类模型对体内肠组织中多细胞组成及其相互作用还原程度有限,且经历体外多次传代后可能无法保留部分遗传特征.类器官和类器官芯片技术的兴起推动了体外模型的技术革新,极大地增强了模拟炎症性肠病体内组织结构与功能的能力,类器官模型对来源组织微环境较好的重现能力也使其能更好预测患者的治疗反应.本文概述了上述模型的研究现状,讨论了各模型的优劣势,并总结了各模型在评价炎症性肠病治疗药物中的应用,以期为后续治疗药物研发和药理机制探索提供合适的研究模型.
Research Progress in the Use of Cell Line and Organoid Models for Studying Inflammatory Bowel Disease
It is important to select a suitable in vitro experimental model to study the pathology and pharmacological mechanisms of inflammatory bowel disease(IBD),thereby developing advanced therapeutic drugs.Immortalized cell lines,as a classic in vitro mod-el,offer several advantages in the research and drug evaluation of IBD,such as high efficiency,low cost,simple operation and intui-tive experimental results.However,these models cannot recapitulate the multicellular composition and intercellular interaction of intes-tinal tissue in vivo and may lose genetic characteristics after multiple passages in vitro.The development of organoids and organs-on-a-chip has promoted the technological innovation of in vitro models by significantly improving our capability to simulate the architecture and function of IBD.The enhanced reproducibility of the organoid model to the microenvironment of the source tissue also confers im-proved predictive capability for patient treatment response.This paper reviews the current research status of these models by discussing their characteristics,advantages,disadvantages,and their applications in evaluation of IBD therapeutic drugs and development of ad-vanced therapeutic drugs,as well as in the exploration of pharmacological mechanisms.

inflammatory bowel diseasecell modelorganoidorgans-on-a-chip

刘盼、刘雪玲、赵青威

展开 >

温州医科大学药学院,浙江温州 325035

浙江大学医学院附属第一医院临床药学部,浙江省药物临床研究与评价技术重点实验室,浙江省中药临床评价与转化研究中医药重点实验室,杭州 310003

炎症性肠病 细胞模型 类器官 类器官芯片

浙江省重点研发计划

2021C01180

2024

中国药学杂志
中国药学会

中国药学杂志

CSTPCD北大核心
影响因子:0.957
ISSN:1001-2494
年,卷(期):2024.59(17)